Skip to main content
. 2018 Aug 23;35:87–96. doi: 10.1016/j.ebiom.2018.08.028

Table 2.

Efficacy of different eradication regimens.

Analysis Group A 95% CI Group B 95% CI P
ITT 88.6%(31/35) 73.3%–96.8% 85.7%(30/35) 69.7%–95.2% 1.000
PP 96.9%(31/32) 83.8%–99.9% 96.8%(30/31) 83.3%–99.9% 1.000

Group A, H. pylori-infected patients treated with bismuth-containing quadruple therapy; Group B, H. pylori-infected patients treated with bismuth-containing quadruple therapy and supplemented with C. butyricum; ITT, intention to treat; PP, per protocol.